ロード中...
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Although current anticancer immunotherapies using immune checkpoint inhibitors (ICIs) have been reported with a high clinical success rate, numerous patients still bear ‘cold’ tumors with insufficient T cell infiltration and low immunogenicity, responding poorly to ICI therapy. Considering the advan...
保存先:
| 出版年: | Nanomicro Lett |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Nature Singapore
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8006526/ https://ncbi.nlm.nih.gov/pubmed/34138315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40820-021-00622-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|